Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions
Vreman, Rick A., PharmD, Heikkinen, Inkatuuli, MSc, MHEcon, Schuurman, Ad, MSc, MBA, Sapede, Claudine, PharmD, Garcia, Jordi Llinares, PhD, Hedberg, Niklas, PharmD, Athanasiou, Dimitrios, MBA, Grueger, Jens, PhD, Leufkens, Hubert G.M., PhD, Goettsch, Wim G., PhD
Published in Value in health (01.11.2019)
Published in Value in health (01.11.2019)
Get full text
Journal Article
Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
Vreman, Rick A, Broekhoff, Thomas F, Leufkens, Hubert Gm, Mantel-Teeuwisse, Aukje K, Goettsch, Wim G
Published in International journal of environmental research and public health (10.11.2020)
Published in International journal of environmental research and public health (10.11.2020)
Get full text
Journal Article
Real World Data in Health Technology Assessment of Complex Health Technologies
Hogervorst, Milou A, Pontén, Johan, Vreman, Rick A, Mantel-Teeuwisse, Aukje K, Goettsch, Wim G
Published in Frontiers in pharmacology (10.02.2022)
Published in Frontiers in pharmacology (10.02.2022)
Get full text
Journal Article
Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study
Kalf, Rachel R J, Delnoij, Diana M J, Ryll, Bettina, Bouvy, Marcel L, Goettsch, Wim G
Published in Journal of medical Internet research (07.12.2021)
Published in Journal of medical Internet research (07.12.2021)
Get full text
Journal Article
Conference Proceeding
Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials
Hong, Yoon Duk, Jansen, Jeroen P, Guerino, John, Berger, Marc L, Crown, William, Goettsch, Wim G, Mullins, C Daniel, Willke, Richard J, Orsini, Lucinda S
Published in BMC medicine (06.12.2021)
Published in BMC medicine (06.12.2021)
Get full text
Journal Article
Challenges and Opportunities for Companies to Build HTA/Payer Perspectives Into Drug Development Through the Use of a Dynamic Target Product Profile
Wang, Ting, McAuslane, Neil, Goettsch, Wim G., Leufkens, Hubert G. M., De Bruin, Marie L.
Published in Frontiers in pharmacology (18.07.2022)
Published in Frontiers in pharmacology (18.07.2022)
Get full text
Journal Article
Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis
Jiu, Li, Hartog, Michiel, Wang, Junfeng, Vreman, Rick A, Klungel, Olaf H, Mantel-Teeuwisse, Aukje K, Goettsch, Wim G
Published in BMJ open (13.02.2024)
Published in BMJ open (13.02.2024)
Get full text
Journal Article
When Reality Does Not Meet Expectations-Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
Callenbach, Marcelien H E, Vreman, Rick A, Mantel-Teeuwisse, Aukje K, Goettsch, Wim G
Published in International journal of environmental research and public health (26.12.2022)
Published in International journal of environmental research and public health (26.12.2022)
Get full text
Journal Article
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)
Schoenmakers, Daphne H, Beerepoot, Shanice, van den Berg, Sibren, Adang, Laura, Bley, Annette, Boelens, Jaap-Jan, Fumagalli, Francesca, Goettsch, Wim G, Grønborg, Sabine, Groeschel, Samuel, van Hasselt, Peter M, Hollak, Carla E M, Lindemans, Caroline, Mochel, Fanny, Mol, Peter G M, Sevin, Caroline, Zerem, Ayelet, Schöls, Ludger, Wolf, Nicole I
Published in Orphanet journal of rare diseases (14.02.2022)
Published in Orphanet journal of rare diseases (14.02.2022)
Get full text
Journal Article
Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
Bloem, Lourens T., Vreman, Rick A., Peeters, Niels W. L., Hoekman, Jarno, Elst, Menno E., Leufkens, Hubert G. M., Klungel, Olaf H., Goettsch, Wim G., Mantel‐Teeuwisse, Aukje K.
Published in Clinical and translational science (01.07.2021)
Published in Clinical and translational science (01.07.2021)
Get full text
Journal Article
The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
Vreman, Rick A, Bloem, Lourens T, van Oirschot, Stijn, Hoekman, Jarno, van der Elst, Menno E, Leufkens, Hubert Gm, Klungel, Olaf H, Goettsch, Wim G, Mantel-Teeuwisse, Aukje K
Published in International journal of health policy and management (01.05.2022)
Published in International journal of health policy and management (01.05.2022)
Get full text
Journal Article
Delayed payment schemes in Central-Eastern Europe and Middle-East
Ádám, Ildikó, Callenbach, Marcelien, Németh, Bertalan, Vreman, Rick A., Pontén, Johan, Strbad, Tea, Dawoud, Dalia, Kostyuk, Alexander, Seyam, Ahmed, Nagy, László, Goettsch, Wim G., Kaló, Zoltán
Published in Frontiers in medicine (12.08.2022)
Published in Frontiers in medicine (12.08.2022)
Get full text
Journal Article
Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision‐making of oncology medicines
Kalf, Rachel R. J., Vreman, Rick A., Delnoij, Diana M.J., Bouvy, Marcel L., Goettsch, Wim G.
Published in Pharmacology research & perspectives (01.04.2021)
Published in Pharmacology research & perspectives (01.04.2021)
Get full text
Journal Article
Relative Effectiveness Assessment of Pharmaceuticals: Similarities and Differences in 29 Jurisdictions
Kleijnen, Sarah, MSc, George, Elisabeth, PhD, Goulden, Scott, MSc, d'Andon, Anne, MD, Vitré, Pauline, PD, MSc, Osińska, Boguslawa, MSc, Rdzany, Rafal, PhD, Thirstrup, Steffen, MD, PhD, Corbacho, Belen, MSc, Nagy, Bence Z., MSc, Leufkens, Hubert G., PhD, de Boer, Anthonius, MD, PhD, Goettsch, Wim G., PhD
Published in Value in health (01.09.2012)
Published in Value in health (01.09.2012)
Get full text
Journal Article
Outcome-based reimbursement in Central-Eastern Europe and Middle-East
Ádám, Ildikó, Callenbach, Marcelien, Németh, Bertalan, Vreman, Rick A., Tollin, Cecilia, Pontén, Johan, Dawoud, Dalia, Elvidge, Jamie, Crabb, Nick, van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh, Pisters-van Roy, Anke, Vincziczki, Áron, Almomani, Emad, Vajagic, Maja, Oner, Z. Gulsen, Matni, Mirna, Fürst, Jurij, Kahveci, Rabia, Goettsch, Wim G., Kaló, Zoltán
Published in Frontiers in medicine (23.09.2022)
Published in Frontiers in medicine (23.09.2022)
Get full text
Journal Article
Can a Joint Assessment Provide Relevant Information for National/Local Relative Effectiveness Assessments? An In-Depth Comparison of Pazopanib Assessments
Kleijnen, Sarah, MSc, Fathallah, Mohammed, MSc, van der Linden, Michiel W., MD, PhD, Vancraeynest, Piet, MD, MScBiostat, Dahmani, Bachir, PhD, Timoney, Angela, MSc, MPH, De Boer, Anthonius, MD, PhD, Leufkens, Hubertus G., PharmD, PhD, Goettsch, Wim G., PhD
Published in Value in health (01.07.2015)
Published in Value in health (01.07.2015)
Get full text
Journal Article
High cost oncology drugs without proof of added benefit are burdening health systems
Brinkhuis, Francine, Goettsch, Wim G, Mantel-Teeuwisse, Aukje K, Bloem, Lourens T
Published in BMJ (Online) (29.02.2024)
Published in BMJ (Online) (29.02.2024)
Get full text
Journal Article